Blood Tests Aim for Earlier Alzheimer’s Diagnosis
UNESCO's life-sciences prize recognizes biomarker and blood-test research that could help people be evaluated for Alzheimer's sooner.
Updated on Nov. 7, 2026 in Alzheimer’s

UNESCO presented Nancy Ip, president of the Hong Kong University of Science and Technology, with the Unesco-Equatorial Guinea International Prize for Research in the Life Sciences on Friday in Paris. The award recognizes her work on Alzheimer's disease, including biomarker discovery and blood tests intended for earlier diagnosis.
Why it matters
Blood-based tests that support earlier diagnosis could change how people with memory concerns are evaluated and monitored over time. The recognition highlights research aimed at identifying the disease earlier, a period when care decisions may carry the most weight.
The prize honors a career body of work rather than a single trial, and the source does not report study designs, sample sizes, or effect sizes for the biomarker or blood-test research. The specific clinical performance of the blood tests is therefore not described here.
The players
UNESCO
The United Nations Educational, Scientific and Cultural Organization, which administers the prize and promotes scientific cooperation worldwide.
Nancy Ip
Neuroscientist and president of the Hong Kong University of Science and Technology, whose research spans Alzheimer's biomarkers, genetic risk factors, and gene therapy for neurodegenerative diseases.
Carlos Martin Montanes
Researcher at the University of Zaragoza in Spain, who was a co-laureate of the prize.
Adnane Remmal
Researcher at Sidi Mohamed Ben Abdellah University of Fez in Morocco, who was a co-laureate of the prize.
The details
Biomarkers are measurable biological signals, such as proteins found in blood or cerebrospinal fluid, that can indicate whether the brain changes associated with Alzheimer's disease are underway. Ip's work identified such biomarkers and genetic risk factors, and her group developed blood tests intended to detect the disease earlier than standard approaches. Ip has also conducted research in gene therapy for neurodegenerative diseases, and she stated that cross-disciplinary cooperation will be important in developing medicines for the condition.
Timeline
2008: UNESCO established the prize, funded by the Republic of Equatorial Guinea.
Friday, November 6, 2026: Ip was presented the prize in Paris.
Health Landscape
The prize, established in 2008 by UNESCO with funding from Equatorial Guinea, has rewarded life-sciences research across several fields. Recognition of Alzheimer's biomarker and blood-test work places a diagnostic focus alongside the disease's treatment research.
If you or a family member are concerned about memory changes, it is worth raising the question of early evaluation with a doctor, since diagnostic tools are an area of active development. Blood-based tests of this kind are not yet a routine part of care, so discuss with your physician what testing options are currently available to you.
The takeaway
Diagnosing Alzheimer's earlier is a major goal of current research, and this award recognizes progress in that direction. Keep an eye on whether the blood tests described here move into clinical validation, and bring any memory concerns to your physician early.
Further reading
For more background on the condition at the center of this award, explore our Alzheimer’s coverage.


